The Medical Marijuana Research Act of 2017 amends the federal law to facilitate clinical investigations involving the use of cannabis and cannabis-derived products.
Yesterday, NORML moderated a Facebook Congressional Conversation on marijuana law reform with Representatives Earl Blumenauer, Tom Garrett, Beto O’Rourke, and Justin Amash.
We discussed a wide range of issues including the needless burden of the federal driver’s license suspension mandate, access to medical marijuana, racial injustice, and pending bipartisan legislation to remove cannabis from the Controlled Substances Act.
This week, the House Appropriations Committee released its 2018 Commerce, Justice, Science (CJS) Appropriations bill, which determines the funding levels for numerous federal agencies, including the Department of Justice. Predictably, the bill does not include language — known as the Rohrabacher-Blumenauer amendment — limiting the Justice Department from taking action against state-sanctioned medical cannabis producers, retailers, or consumers.
NORML held a ‘Faces of Marijuana Prohibition’ event on Capitol Hill on April 19th, in cooperation with the Congressional Cannabis Caucus, where congressional staff heard first-hand from those most adversely impacted by the criminalization of marijuana.
Did you catch it? On Last Week Tonight, host John Oliver skewered our nation’s failed policy of marijuana prohibition addressing topics ranging from a potential crackdown from Attorney General Jeff Sessions, the newly formed Cannabis Caucus, and the desperate need for federal marijuana law reform.
Senator Ron Wyden and Representatives Earl Blumenauer and Jared Polis have introduced legislation in the House and Senate — The Marijuana Revenue and Regulation Act — to permit states to establish their own marijuana regulatory policies free from federal interference.
Engaging elected officials is a primary function of NORML and all its affiliates. As the Michigan Affiliate of NORML, we are pleased to participate in this and other NORML nationally-coordinated campaigns that reach out to federal representatives in a collaborative way that reinforces the strength of support for cannabis reforms.